The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
1 H NMR metabonomics approach to the disease continuum of diabetic complications and premature death
Open accessAbstract
Subtle metabolic changes precede and accompany chronic vascular complications, which are the primary causes of premature death in diabetes. To obtain a multimetabolite characterization of these high‐risk individuals, we measured proton nuclear magnetic resonance (1H NMR) data from the serum of 613 patients with type I diabetes and a diverse spread of complications. We developed a new metabonomics framework to visualize and interpret the data and to link the metabolic profiles to the underlying diagnostic and biochemical variables. Our results indicate complex interactions between diabetic kidney disease, insulin resistance and the metabolic syndrome. We illustrate how a single 1H NMR protocol is able to identify the polydiagnostic metabolite manifold of type I diabetes and how its alterations translate to clinical phenotypes, clustering of micro‐ and macrovascular complications, and mortality during several years of follow‐up. This work demonstrates the diffuse nature of complex vascular diseases and the limitations of single diagnostic biomarkers. However, it also promises cost‐effective solutions through high‐throughput analytics and advanced computational methods, as applied here in a case that is representative of the real clinical situation. People with diabetes are at high risk of dying from heart disease and stroke, and many patients also suffer from severe degradation of the kidneys, retina and nervous system. Diabetes‐related diseases reflect the imbalance of glucose metabolism: patients with type I diabetes completely lack the normal insulin response that makes glucose available for cellular processes. With insulin replacement therapy the acute symptoms can be cured, but the natural metabolic balance is nevertheless disturbed, which leads to chronic systemic stress. Diabetic kidney disease (DKD) is an important predictor of premature death in type I diabetes. Its absence does not, however, preclude other risk factors for heart disease. Furthermore, the clinical diagnosis is based on a single biomarker (excess protein in urine) and subject to large individual variation that makes the early stages difficult to detect. We are therefore developing new cost‐effective analytical and computational approaches that can augment the existing biomarkers and provide a quantitative multidimensional disease characterization. In this study, we measured the 1H NMR spectra of blood serum for 613 patients with type I diabetes from the Finnish Diabetic Nephropathy Study. We chose 1H NMR spectroscopy, as it can detect many of the important risk markers (such as cholesterol, triglycerides, glucose and creatinine) with a single standardized experimental procedure (Figure 1). Our starting point was exploratory—we did not try to predict urine protein excretion, but rather to identify the diverse and diffuse systemic metabolic states of the diabetic condition, as seen in serum. The complex molecular data cannot be used as such; we thus visualized the spectral features with a self‐organizing map (SOM). Simply speaking, the SOM is just a layout of patients on a 2D canvas in such a way that patients with similar spectra are placed close to each other. Consequently, the map can be colored according to locally averaged values for a particular variable, which reveals the differences in the metabolic profiles between specific map regions. We also developed a new method to estimate the statistical significance of the observed patterns and to normalize the colorings, so that different sources of information can be easily visualized and reliably compared (Figure 1). Our results show that in the study group (aged between 30 and 50 years) mortality during the next decade was over three times higher than in the same age group of the entire Finnish population (Figure 6). Most of the premature deaths were attributed to the combination of DKD and adverse serum profile (eightfold relative risk). Note that none of the patients was on dialysis, so they still had adequate kidney function. The spectral features for these patients revealed hallmarks of insulin resistance that are characteristic of additional disturbance in glucose metabolism besides the insulin deprivation. High concentration of triglycerides, elevated total cholesterol and a decrease in high‐density lipoprotein particles (HDL2) were observable in the 1H NMR spectra, along with an increase of creatinine, which is associated with reduced filtering capacity of the kidneys. Lactate and acetate were also different between the high‐ and low‐risk groups, which further indicates alterations in cellular glucose metabolism (Figure 1). In addition to the 1H NMR spectra, we also had numerous biochemical measurements and extensive clinical information available for the study subjects. The coalescent nature of kidney disease and insulin resistance was confirmed by overlapping the SOM patterns for urine albumin excretion, weight‐adjusted insulin dose, glycosylated hemoglobin (measure of long
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gerstein, H. C. (2001) · JAMA · doi:10.1001/jama.286.4.421 · Cited by 2,440
Mortality and causes of death in the WHO Multinational Study of Vascular Disease in Diabetes
and the WHO Multinational Study Group, Morrish, N. J., Wang, S.-L., Stevens, L. K., Fuller, J. H., & Keen, H. (2001) · Diabetologia · doi:10.1007/pl00002934 · Cited by 1,288
Pharmaco-metabonomic phenotyping and personalized drug treatment
Andrew Clayton, T., Lindon, J. C., Cloarec, O., Antti, H., Charuel, C., Hanton, G., Provost, J.-P., Le Net, J.-L., Baker, D., Walley, R. J., et al. (2006) · Nature · doi:10.1038/nature04648 · Cited by 824 · cited 4×
“Animal models have provided encouraging results and further justification for the metabonomic NMR approach (Williams et al, 2005; Clayton et al, 2006; Salek et al, 2007), but more experience from human populations is needed (Griffin and Nicholls, 2006; Ala-Korpela, 2007).”
BackgroundInfluentialA genome-wide association study identifies KIAA0350 as a type 1 diabetes gene
Hakonarson, H., Grant, S. F. A., Bradfield, J. P., Marchand, L., Kim, C. E., Glessner, J. T., Grabs, R., Casalunovo, T., Taback, S. P., Frackelton, E. C., et al. (2007) · Nature · doi:10.1038/nature06010 · Cited by 542
Libby, P., Nathan, D. M., Abraham, K., Brunzell, J. D., Fradkin, J. E., Haffner, S. M., Hsueh, W., Rewers, M., Roberts, B. T., Savage, P. J., et al. (2005) · Circulation · doi:10.1161/circulationaha.104.529651 · Cited by 265
Pambianco, G., Costacou, T., & Orchard, T. J. (2007) · Diabetes Care · doi:10.2337/dc06-2053 · Cited by 198
Cited by
Soininen, P., Kangas, A. J., Würtz, P., Suna, T., & Ala-Korpela, M. (2015) · Circulation: Cardiovascular Genetics · doi:10.1161/circgenetics.114.000216 · Cited by 900
Self-citationWürtz, P., Kangas, A. J., Soininen, P., Lawlor, D. A., Davey Smith, G., & Ala-Korpela, M. (2017) · American Journal of Epidemiology · doi:10.1093/aje/kwx016 · Cited by 686
Self-citationAnalytical Methods in Untargeted Metabolomics: State of the Art in 2015
Alonso, A., Marsal, S., & JuliÃ, A. (2015) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2015.00023 · Cited by 681
High-throughput serum NMR metabonomics for cost-effective holistic studies on systemic metabolism
Soininen, P., Kangas, A. J., Würtz, P., Tukiainen, T., Tynkkynen, T., Laatikainen, R., Järvelin, M.-R., Kähönen, M., Lehtimäki, T., Viikari, J., et al. (2009) · The Analyst · doi:10.1039/b910205a · Cited by 589
Self-citationChemometrics in metabolomics—A review in human disease diagnosis
Madsen, R., Lundstedt, T., & Trygg, J. (2010) · Analytica Chimica Acta · doi:10.1016/j.aca.2009.11.042 · Cited by 557
Metadata
- Authors
- Mäkinen, V., Soininen, P., Forsblom, C., Parkkonen, M., Ingman, P., Kaski, K., Groop, P., & Ala‐Korpela, M.
- Venue
- Molecular Systems Biology
- Published
- 2008-01
- Volume
- 4
- Issue
- 1
- Pages
- 167-167
- ISSN
- 1744-4292 (ISSN-L)
- OpenAlex
- W1992029609
- Cited by
- 158
- References
- 7
- FWCI
- 8.31
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: 1 H NMR metabonomics approach to the disease continuum of diabetic complications and premature death. https://app.cochat.ai/papers/10.1038/msb4100205
- The paper
- Mäkinen, V., Soininen, P., Forsblom, C., Parkkonen, M., Ingman, P., Kaski, K., Groop, P., & Ala‐Korpela, M. (2008). 1 H NMR metabonomics approach to the disease continuum of diabetic complications and premature death. Molecular Systems Biology. https://doi.org/10.1038/msb4100205
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.